Document is current
Any future updates will be listed below
-
Authors
Ritter, David M. https://orcid.org/0000-0001-7723-3636
Fessler, Bailey K.
Ebrahimi-Fakhari, Daniel
Wei, Jun
Franz, David N.
Krueger, Darcy A.
Trout, Andrew T.
Towbin, Alexander J.
-
Funding
Funding for this research was provided by:
University of Cincinnati College of Medicine Office of Research
German Tuberous Sclerosis Foundation
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 7 March 2022
First Online: 15 March 2022
Declarations
:
: All patients, or their legal guardian(s), consented for the Cincinnati Children’s Hospital TSC Repository Database as approved by and study conducted according to the CCHMC Internal Review Board (IRB #2012-2317).
: All patients, or their legal guardian(s), consented for publication as a part of the Cincinnati Children’s Hospital TSC Repository Database as approved by the CCHMC Internal Review Board (IRB #2012-2317).
: DMR, BKF, DEF, JW, DNF, ATT, and AJT declare that they have no competing interests related to this work. DAK recieves consulting and/or speaker fees from Novartis Pharmaceuticals, Greenwich Bioscience, NobelPharma America, and REGENXBIO. Unrelated to this work: ATT receives consulting fees from Lantheus and AJT receives consulting fees from Applied Radiology.
